Showing results (801-810 of 833) with videos related to

Sort By:
Pageof 84
The Lancet. Infectious Diseases|March 1, 2011
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort studyLinda Wittkop, Huldrych F Günthard, Frank de Wolf, et al.
BMJ Open|March 14, 2012
Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trialJens-Ulrik Stæhr Jensen, Lars Hein, Bettina Lundgren, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2020
Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort SettingLauren Greenberg, Lene Ryom, Gilles Wandeler, et al.
BMC Infectious Diseases|July 16, 2008
The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patientsJens-Ulrik Jensen, Bettina Lundgren, Lars Hein, et al.
The Lancet. Respiratory Medicine|January 13, 2018
Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trialTheis Skovsgaard Itenov, Maria Egede Johansen, Morten Bestle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2016
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized TrialsÁlvaro H Borges, Andreas Lundh, Britta Tendal, et al.
Clinical Trials (London, England)|October 11, 2021
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)Daniel D Murray, Abdel G Babiker, Jason V Baker, et al.
HIV Medicine|October 25, 2019
The EuroSIDA study: 25 years of scientific achievementsK Laut, O Kirk, J Rockstroh, et al.
Plos Medicine|October 19, 2013
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)Amanda Mocroft, Jens D Lundgren, Miriam Lewis Sabin, et al.
The Lancet. HIV|January 7, 2023
Recommendations for defining preventable HIV-related mortality for public health monitoring in the era of Getting to Zero: an expert consensusSara E Croxford, Veronique Martin, Sebastian B Lucas, et al.
Pageof 84